R. Gruber James's most recent trade in Eton Pharmaceuticals Inc was a trade of 40,655 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 40,655 | 254,075 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 25,856 | 279,931 | - | - | Restricted Stock Units | |
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.47 per share. | 12 Jan 2026 | 2,293 | 213,420 (1%) | 0% | 15.5 | 35,473 | Common Stock |
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2025 | 5,502 | 210,255 | - | - | Restricted Stock Units | |
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.99 per share. | 11 Dec 2025 | 4,542 | 215,713 (1%) | 0% | 17.0 | 77,169 | Common Stock |
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.16 per share. | 19 Aug 2025 | 39,082 | 205,299 (1%) | 0% | 16.2 | 631,565 | Common Stock |
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.02 per share. | 19 Aug 2025 | 2,631 | 204,753 (1%) | 0% | 16.0 | 42,149 | Common Stock |
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 38,621 | 38,621 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 25,876 | 25,876 | - | - | Restricted Stock Units | |
| Eton Pharma Inc | R. Gruber James | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 144,677 | 374,763 | - | - | Stock Option (Right to buy) | |
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 100,086 | 200,086 | - | - | Stock Option (right to buy) | |
| Eton Pharma Inc | James R. Gruber | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 40,000 | 40,000 | - | - | Restricted Stock Units |